Toxoplasmosis-associated neovascular lesions treated successfully with ranibizumab and antiparasitic therapy

Joseph D. Benevento, MD1, Rama D. Jager, MD, MBA1, A. Gwendolyn Noble, MD, PhD2, Paul Latkany, MD1,3, William F. Mieler, MD1, Mari Sautter, BA1, Sanford Meyers, MD1, Marilyn Mets, MD2, Michael A. Grassi, MD1, Peter Rabiah, MD1, Kennneth Boyer, MD4, Charles Swisher, MD2, and Rima McLeod, MD1,* other members of the Toxoplasmosis Study Group† 1University of Chicago Pritzker School of Medicine, Chicago, IL 2Children’s Memorial Hospital, Chicago, IL 3St. Luke’s Roosevelt Hospital, The New York Eye & Ear Infirmary, New York, NY 4Rush University Medical Center, Chicago, IL